HELE · Helen Of Troy Ltd
Market Cap
$624.46M
Shares
23.29M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$26.81
Open$27.00
Day$26.31–27.24
52W close$13.88–30.22
Avg vol 30d347K
Short int3.0M · 12.7% float · 7.9d
Short vol80%
Last earningsJul 8, 2026
DataJan 2020–Sep 2026
Filing10-Q · Jul 8
Up next
Next earnings call
Oct 7, 2026
Est · unconfirmed
· in 3 wks
filed Jul 8, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.82B
Trailing 12 months
Net income (TTM)
−$412.50M
Trailing 12 months
Revenue growth YoY
+8.2%
Year over year
Operating margin
-17.3%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
12.9%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$694.47M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.6%
Year over year · more shares
Price change (1Y)
+8.5%
Trailing year
Short interest
12.7%
Latest settlement · 7.9 days to cover
Mentioned in fund letters
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+19%
above
Price vs 50-day avg
−5%
below
RSI (14)
41
neutral
MACD trend
Negative
52-week position
79%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−11%
trailing
6-month return
+81%
trailing
YTD return
+26%
this year
Relative strength
+63%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $28 › 200d $23 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +47 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
12.70% of float · ▲ +4.6% MoM · 7.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
204 holders — mid 3-yr range
Squeeze score
68
elevated · 0–100
Fundamentals
Revenue growth
+6%
Y/Y
Gross margin
55%
contracting
EPS growth
−828%
Y/Y
Buyback
$496.8M
remaining
Balance sheet
$761.9M
net debt
Quant / Vol
risk profile
Volatility
60%
annualized · 1-yr
Max drawdown
−50%
past year
ATR
4.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 8, 2026
Home & Outdoor Net Sales
· Fiscal 2027
Initiated
$859M – $884M
Beauty & Wellness Net Sales
· Fiscal 2027
Initiated
$900M – $947M
Adjusted Diluted EPS (Non-GAAP)
· Fiscal 2027
Initiated
$3.25 – $3.75
Diluted EPS (GAAP)
· Fiscal 2027
Initiated
$3.57 – $4.18
prior FY $-39.08
midpoint +109.9% Y/Y
Operating Cash Flow (GAAP)
· Fiscal 2027
Initiated
$119M – $130M
Consolidated Net Sales
· Fiscal 2027
Initiated
$1.76B – $1.83B
prior FY $1.79B
midpoint +0.5% Y/Y
Free Cash Flow
· Fiscal 2027
Initiated
$85M – $100M
Adjusted effective tax rate
· Fiscal 2027
Initiated
24% – 26%
GAAP effective tax rate
· Fiscal 2027
Initiated
27.2% – 29.7%
Prior guidance
period ended
· from the 8-K filed Jul 9, 2024
GAAP Diluted EPS
· fiscal 2025
$4.69 – $5.45
Adjusted EBITDA
· fiscal 2025
$287M – $297M
Free Cash Flow
· fiscal 2025
$220M – $240M
Adjusted Diluted EPS
· fiscal 2025
$7.00 – $7.50
Consolidated net sales revenue
· Fiscal 2025
$1.89B – $1.94B
Interest expense
· Fiscal 2025
$44M – $46M
Reported GAAP effective tax rate
· full fiscal year 2025
27.3% – 29.5%
Adjusted effective tax rate
· full fiscal year 2025
20.7% – 21.3%
Guided vs delivered
· last 4 settled
GAAP Diluted EPS
fiscal 2025
guided $4.69 – $5.45
$5.37
In line
Consolidated net sales revenue
Fiscal 2025
guided $1.89B – $1.94B
$1.91B
In line
Consolidated net sales revenue
fiscal year
guided $2.1B – $2.12B
$2.22B
Beat +5.4%
Consolidated GAAP diluted EPS
fiscal year
guided $8.25 – $8.59
$9.17
Beat +8.9%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+19%
Bullish
Price vs 50-day avg
−5%
Bearish
RSI (14)
41
Neutral
MACD trend
Negative
Bearish
52-week position
79%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $28 › 200d $23 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +47 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
12.70% of float · ▲ +4.6% MoM · 7.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
204 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $14
Now $27 · 79%
Range high $30
vs 200-day avg +19%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HELE
this stock
Helen Of Troy Ltd
|
$624.46M | +26.2% | +5.8% | — | 12.7% |
|
PG
PROCTER & GAMBLE Co
|
$337.67B | +1.4% | +3.3% | 21.9 | 1.2% |
|
UL
Unilever PLC
|
$133.55B | -5.2% | — | — | 0.2% |
|
CL
Colgate Palmolive Co
|
$69.19B | +9.8% | +1.7% | 34.3 | 2.2% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$43.33B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HELE | -4.9% | -10.6% | +80.5% | -10.9% | +26.2% |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | -3.7% | -8.9% | +62.7% | -10.6% | +14.1% |
Capital returns
Buyback program
· as of May 31, 2026
Authorized
$500.00M
Spent (derived)
$3.20M
Remaining
$496.80M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
916789
CUSIP
G4388N106
13F (30d)
66 filings
66 filers
Visit website
Investor relations